Rüdiger Hilker

Overview

Best Publications

• A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease

  Günther Deuschl;Carmen Schade-Brittinger;Paul Krack;Jens Volkmann

  3369
  Citations

• Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study

  Karsten Witt;Christine Daniels;Julia Reiff;Paul Krack

  755
  Citations

• Dementia in Parkinson disease Functional imaging of cholinergic and dopaminergic pathways

  Rüdiger Hilker;A. V. Thomas;J. C. Klein;S. Weisenbach

  434
  Citations

• Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

  Johannes C. Klein;Carsten Eggers;Elke Kalbe;S. Weisenbach

  403
  Citations

• Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.

  Peter P. Pramstaller;Michael G. Schlossmacher;Michael G. Schlossmacher;Thomas S. Jacques;Francesco Scaravilli

  331
  Citations

• 18F-Fluoro-l-Thymidine and 11C-Methylmethionine as Markers of Increased Transport and Proliferation in Brain Tumors

  Andreas H. Jacobs;Anne Thomas;Lutz W. Kracht;Huongfeng Li

  310
  Citations

• Decision-making impairments in patients with Parkinson's disease.

  Matthias Brand;Kirsten Labudda;Elke Kalbe;Rüdiger Hilker

  307
  Citations

• Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging

  Mehran Ghaemi;R. Hilker;J. Rudolf;Jan Sobesky

  303
  Citations

• Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument

  Elke Kalbe;Pasquale Calabrese;Nils Kohn;Rüdiger Hilker

  283
  Citations

• Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease.

  Simon Baudrexel;Torsten Witte;Carola Seifried;Frederic von Wegner

  275
  Citations

• Thirty days complication rate following surgery performed for deep-brain-stimulation.

  Jürgen Voges;Rüdiger Hilker;Kai Bötzel;Karl L. Kiening

  261
  Citations

• Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease

  Elke Hattingen;Jörg Magerkurth;Ulrich Pilatus;Anne Mozer

  250
  Citations

• Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation.

  Rüdiger Hilker;A. T. Portman;J. Voges;M. J. Staal

  214
  Citations

• Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease.

  Simon Baudrexel;Lucas Nürnberger;Udo Rüb;Carola Seifried

  177
  Citations

• Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?

  Katja Hedrich;Johann Hagenah;Ana Djarmati;Anja Hiller

  157
  Citations

• Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.

  Hans-Jürgen Huppertz;Leona Möller;Martin Südmeyer;Rüdiger Hilker

  148
  Citations

• Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study

  Alexander Thiel;Rüdiger Hilker;Josef Kessler;Birgit Habedank

  148
  Citations

• Diffusion tensor imaging of white matter involvement in essential tremor.

  Johannes C. Klein;Benedikt Lorenz;Jun-Suk Kang;Simon Baudrexel

  127
  Citations

• Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion

  Jan Sobesky;Alexander Thiel;Mehran Ghaemi;Rüdiger H. Hilker

  124
  Citations

• Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease

  Simone van de Loo;Uwe Walter;Stefanie Behnke;Johann Hagenah

  124
  Citations